François Venter, MD, FCP

Dr. Willem Daniel Francois Venter, MD, FCP is the Deputy Executive Director of the Wits Reproductive Health and HIV Institute at the University of the Witwatersrand. He leads multiple antiretroviral treatment optimisation studies, and has an active interest in public sector access to HIV services. He is currently working on new first and second line antiretroviral options, patient linkage to care interventions, and self-testing projects. Previously, he lead large PEPFAR-funded HIV programmes in South Africa, including one that focused on truckers and sex workers. He has been represented on South African and regional guidelines for over a decade, having done almost all his training within South Africa.

His major research currently focus on low dose stavudine, low dose darunavir in second line treatment, and combinations of newer drugs to improve the resistance and potency of first line, as well as using patient information to drive improved linkage to care after diagnosis.